Press releases

Scholar Rock Announces Initiation of Patient Dosing in Phase 2 Trial of SRK-015 in Spinal Muscular Atrophy

Read This Press Release

Scholar Rock Appoints Akshay Vaishnaw, M.D., Ph.D. to Its Board of Directors

Read This Press Release

Scholar Rock Announces Appointment of Lisa Amaya Price as Senior Vice President, Human Resources

Read This Press Release

Scholar Rock Presents Additional Preclinical Data Demonstrating a Highly Specific Inhibitor of TGFβ1 Activation Can Render Resistant Solid Tumors Vulnerable to PD1 Blockade and Drive Tumor Regression with Combination Therapy

Read This Press Release

Scholar Rock Reports Full Year 2018 Financial Results and Highlights Business Progress

Read This Press Release

Scholar Rock to Develop Cancer Immunotherapy Product Candidate, SRK-181, a Selective Inhibitor of TGFβ1 Activation, to Overcome Checkpoint Inhibitor Resistance

Read This Press Release

Scholar Rock to Participate in Upcoming Investor Conferences

Read This Press Release

Scholar Rock Announces Positive Interim Results from Phase 1 Trial of SRK-015 in Healthy Volunteers and Updates on Future Development Plans

Read This Press Release